These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 27313184)
41. Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes. Warwick D; Arner M; Pajardi G; Reichert B; Szabo Z; Masmejean EH; Fores J; Chapman DS; Gerber RA; Huard F; Seghouani A; Szczypa PP; J Hand Surg Eur Vol; 2015 Feb; 40(2):124-32. PubMed ID: 24470559 [TBL] [Abstract][Full Text] [Related]
42. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613 [TBL] [Abstract][Full Text] [Related]
43. Can collagenase effectiveness in Dupuytren's contracture be improved by using ultrasound-guided Injection? A comparative study. Aguilella L; Pérez-Giner R; Higueras-Guerrero V; Belloch-Ramos E; Cuenca-Torres M; Juan EL J Plast Surg Hand Surg; 2022 Feb; 56(1):23-29. PubMed ID: 33840343 [TBL] [Abstract][Full Text] [Related]
44. What is the better treatment for single digit dupuytren's contracture: surgical release or collagenase clostridium histolyticum (Xiapex) injection? Povlsen B; Povlsen SD Hand Surg; 2014; 19(3):389-92. PubMed ID: 25155703 [TBL] [Abstract][Full Text] [Related]
45. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951 [TBL] [Abstract][Full Text] [Related]
47. Factors predicting the 1-year outcome of collagenase treatment for Dupuytren's disease. Scheibler AG; Marks M; Hensler S; Herren DB; Calcagni M Arch Orthop Trauma Surg; 2019 Apr; 139(4):583-588. PubMed ID: 30673868 [TBL] [Abstract][Full Text] [Related]
48. Botulinum toxin as an adjunct for severe Dupuytren's contracture treated with collagenase injections. Denkler KA; Cheng J; Song S; Hansen S Arch Clin Cases; 2022; 9(4):133-135. PubMed ID: 36628168 [TBL] [Abstract][Full Text] [Related]
49. Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease : an observational study in Belgium. Verstreken F; Degreef I; Decramer A; Libberecht K; Vanhove W; Datco A; Vanhaecke J; Clermont D; Duerinckx J Acta Orthop Belg; 2016 Aug; 82(2):397-404. PubMed ID: 27682305 [TBL] [Abstract][Full Text] [Related]
50. Resource utilisation associated with single digit Dupuytren's contracture treated with either surgery or injection of collagenase Clostridium histolyticum. Povlsen B; Shields AM; Bhabra GS Hand Surg; 2014; 19(2):205-9. PubMed ID: 24875504 [TBL] [Abstract][Full Text] [Related]
51. Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture. Naam NH Hand (N Y); 2013 Dec; 8(4):410-6. PubMed ID: 24426958 [TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture. Muppavarapu RC; Waters MJ; Leibman MI; Belsky MR; Ruchelsman DE Hand (N Y); 2015 Jun; 10(2):260-5. PubMed ID: 26034441 [TBL] [Abstract][Full Text] [Related]
53. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum. Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067 [TBL] [Abstract][Full Text] [Related]